Leaderboard

En | De
Sie sind hier: Gastroenterologie » Magen-Darm » Neoplasie 10. November 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Diarrhoe
Entzündliche Darmerkrankungen
Funktionelle Beschwerden
Gastroenteritis
Gastrointestinale Hämorrhagie
Neoplasie
Peptische Ulzera
Anderes
Oesophagus
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 12357  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 247132  
   
Identification of key indicators of colorectal cancer risk in patients with diabetes mellitus using machine learning and Mendelian randomization.
Endokrynol Pol
Shangguan H, Li J, Sun R, Xie Z, Wang C, Wang Z, Huang X, Wang S.
PMID: 43006189 [PubMed - as supplied by publisher]


Mixed adeno-neuroendocrine neoplasm (MiNEN) of the small intestine presenting as sub-occlusive syndrome: a rare and challenging diagnosis.
Int J Surg Case Rep
Aabalou M, Vadel AJ, Derkaoui A, Guellil A, Jabi R, Bouziane M.
PMID: 43006110 [PubMed]


An Integrative Medicine Colorectal Screening (IMCS) Model for Predicting Colorectal Neoplasm: A Cross-Sectional Study of 2,047 Participants.
Int J Gen Med
Liu C, Shuai Y, Ye H, Ng CS, Hu F, Fan L, Cheng S, Zhang B, Zhang H, Liu T, Chen XL, Zhong C.
PMID: 43005915 [PubMed]


Spatial immune architecture and immunotherapy resistance in microsatellite-stable colorectal cancer.
Front Immunol
Liu X, Liao Q, Cheng Y, Zhou H, Wang R.
PMID: 43005765 [PubMed - indexed for MEDLINE]


Natural killer cells in colorectal cancer liver metastasis: redefining immune surveillance and plasticity.
Front Oncol
Lu Y, Xia C, Gu J.
PMID: 43005697 [PubMed]


Fusobacterium nucleatum-associated metabolites in disease pathogenesis: from cancer to immunotherapy.
Front Microbiol
Farah H, PadmaPriya G, Sahoo S, Alhasso B, Srivastav SK, Rani A, Singh R, Khdyr AH.
PMID: 43005681 [PubMed]


Clinical translation of liquid biopsy in early cancer screening: biofluid selection, model construction, and clinical validation.
Front Oncol
Cui P, Xu S, Lin X, Song S, Huang B, Xu Z.
PMID: 43005646 [PubMed]


Engineered organoid platforms for mechanistic studies of gut microbiota-cancer interactions.
Front Bioeng Biotechnol
Sun M, Jiao JM, Zang D, Lin MX, Zhou H, Chen J.
PMID: 43005560 [PubMed]


CT referrals and cancer detection in patients referred by general practitioners with non-specific symptoms and signs of cancer: A retrospective study.
Acta Radiol Open
Ohana NL, Axelsen J, Wilkinson MS, Graumann O, Sivesgaard K, Buus TW, Vedsted P, Midtgaard A, Greve SB, Larsen SKA.
PMID: 43005528 [PubMed]


CXCR2 associated neutrophil stromal interactions and immune exclusion in microsatellite stable colorectal cancer.
Front Immunol
Peng T, He X.
PMID: 43005455 [PubMed - indexed for MEDLINE]


Crosstalk between IL-6/JAK/STAT3 and TNF-α/NF-κB signaling in colitis-associated colorectal cancer: epigenetic reprogramming, evidence boundaries, and opportunities for disease management.
Front Immunol
Yuan J, Liao J, Li F, Xie D, Zuo Z, Zhang D, Zhang T.
PMID: 43005443 [PubMed - indexed for MEDLINE]


Public omics data reuse in gastric cancer: from discovery abundance to translational evidence.
Front Oncol
Su S, Huang C, Yang B, Huang Y, Yang P, Liu A.
PMID: 43005429 [PubMed]


Fruquintinib Plus FOLFIRI/FOLFOX as Second-Line Therapy in Patients With RAS-Mutant Metastatic Colorectal Cancer: A Multicenter, Open-Label, Single-Arm Phase II Study.
MedComm (2020)
Xu Y, Li C, Zeng Y, Wu Y, Dai Y, Ji X, Cui Z, Zhu X, Tang M, Xu Y.
PMID: 43005371 [PubMed]


Interplay Between Endolysosomal Calcium Signalling, EMT, and Autophagy in Colorectal Cancer (CRC): Implications for Metastasis and Therapeutic Strategies.
Adv Pharm Bull
Affendie NAN, Ab Aziz NS, Jamaludin SYN, Abd Latip N, Jahidin AH.
PMID: 43005244 [PubMed]


Epigenetic Regulation of Cell Cycle Control in Colorectal Cancer: Molecular Mechanisms and Therapeutic Perspectives.
Adv Pharm Bull
B S, Jeeragyal DP, Velukuri K, Reganti A, S V, Ramalingam V, Sreerama R, Grandhe N, Hoogar P.
PMID: 43005222 [PubMed]


GAS5 in Colorectal Cancer: A Multifaceted Long Non-Coding RNA in Tumor Suppression, Prognosis and Therapeutic Targeting.
Adv Pharm Bull
Ong J, Sritharan SK, Arifin AH, Gunasekaran B, Koh RY, Abu Bakar N, Salvamani S.
PMID: 43005145 [PubMed]


Therapeutic Targeting of the Cancer Microbiome and Metabolome: Ongoing Trials and Future Directions for the Surgical Oncologist.
J Surg Oncol
Nachman EJ, Neilson T, White MG.
PMID: 43004864 [PubMed - as supplied by publisher]


Phase 1b breast cancer prevention clinical trial of 9cUAB30 administered prior to surgical resection.
Cancer Prev Res (Phila)
Krontiras H, Wilke LG, DeShong K, Chaubal K, Zhang J, Hutson PR, Green H, Havighurst TC, Kim K, Chappell RJ, Barroilhet L, McGregor SM, Esbona K, Stanton SE, Hui J, Khan SA, Yang ES, Sauter ER, Heckman-Stoddard BM, Dimond E, House M, Bailey HH.
PMID: 43004857 [PubMed - as supplied by publisher]


Stereotactic ablative radiotherapy and immunotherapy in metastatic colorectal cancer: overcoming immune resistance through immune priming.
Future Oncol
Jalali P, Shahmoradi A, Ellsworth S, Jafari F, Saeed A.
PMID: 43004690 [PubMed - as supplied by publisher]


Dual roles of ANXA7 in the early diagnosis and prognostic prediction of colorectal cancer: insights from serum exosome proteomics and single-cell transcriptomics.
J Nanobiotechnology
Yang DX, Yu H, Wen JF, Xiang S, Wang R, Li T, Hu K, Zhou Y, Ye G, Yang P.
PMID: 43004430 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 247132    Seite 1 von 12357  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Sky right 1